Cargando…
Cyclo(His-Pro): A further step in the management of steatohepatitis
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) have become the world's most common liver diseases, placing a growing strain on healthcare systems worldwide. Nonetheless, no effective pharmacological treatment has been approved. The naturally occurrin...
Autores principales: | De Masi, Alessia, Li, Xiaoxu, Lee, Dohyun, Jeon, Jongsu, Wang, Qi, Baek, Seoyeong, Park, Onyu, Mottis, Adrienne, Strotjohann, Keno, Rapin, Alexis, Jung, Hoe-Yune, Auwerx, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432811/ https://www.ncbi.nlm.nih.gov/pubmed/37600955 http://dx.doi.org/10.1016/j.jhepr.2023.100815 |
Ejemplares similares
-
CycloZ Improves Hyperglycemia and Lipid Metabolism by Modulating Lysine Acetylation in KK-Ay Mice
por: Jeon, Jongsu, et al.
Publicado: (2023) -
The Role of Cyclo(His-Pro) in Neurodegeneration
por: Grottelli, Silvia, et al.
Publicado: (2016) -
Lysosomes mediate the mitochondrial UPR via mTORC1-dependent ATF4 phosphorylation
por: Li, Terytty Yang, et al.
Publicado: (2023) -
Cyclic Peptides in Neurological Disorders: The Case of Cyclo(His-Pro)
por: Bellezza, Ilaria, et al.
Publicado: (2019) -
SIRT2 Deficiency Modulates Macrophage Polarization and Susceptibility to Experimental Colitis
por: Lo Sasso, Giuseppe, et al.
Publicado: (2014)